DK1616869T3 - Substituerede porphyriner og deres terapeutiske anvendelse - Google Patents
Substituerede porphyriner og deres terapeutiske anvendelseInfo
- Publication number
- DK1616869T3 DK1616869T3 DK05014279.3T DK05014279T DK1616869T3 DK 1616869 T3 DK1616869 T3 DK 1616869T3 DK 05014279 T DK05014279 T DK 05014279T DK 1616869 T3 DK1616869 T3 DK 1616869T3
- Authority
- DK
- Denmark
- Prior art keywords
- therapeutic use
- substituted porphyrins
- oxidants
- relates
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/555—Heterocyclic compounds containing heavy metals, e.g. hemin, hematin, melarsoprol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/409—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil having four such rings, e.g. porphine derivatives, bilirubin, biliverdine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/22—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains four or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B47/00—Porphines; Azaporphines
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Toxicology (AREA)
- Cardiology (AREA)
- Rheumatology (AREA)
- Obesity (AREA)
- Ophthalmology & Optometry (AREA)
- Pain & Pain Management (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Vascular Medicine (AREA)
- Biochemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11701099P | 1999-01-25 | 1999-01-25 | |
EP00905776A EP1155019B1 (en) | 1999-01-25 | 2000-01-25 | Substituted porphyrins and their therapeutic use |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1616869T3 true DK1616869T3 (da) | 2012-05-07 |
Family
ID=22370524
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00905776T DK1155019T3 (da) | 1999-01-25 | 2000-01-25 | Substituerede porphyriner og deres terapeutiske anvendelse |
DK05014279.3T DK1616869T3 (da) | 1999-01-25 | 2000-01-25 | Substituerede porphyriner og deres terapeutiske anvendelse |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK00905776T DK1155019T3 (da) | 1999-01-25 | 2000-01-25 | Substituerede porphyriner og deres terapeutiske anvendelse |
Country Status (18)
Country | Link |
---|---|
US (7) | US6544975B1 (da) |
EP (3) | EP2295435A1 (da) |
JP (1) | JP4501128B2 (da) |
KR (1) | KR100753184B1 (da) |
CN (1) | CN1156478C (da) |
AT (2) | ATE312103T1 (da) |
AU (1) | AU779283B2 (da) |
BR (1) | BR0007720B1 (da) |
CA (1) | CA2359116C (da) |
DE (1) | DE60024588T2 (da) |
DK (2) | DK1155019T3 (da) |
ES (2) | ES2254142T3 (da) |
HK (2) | HK1047744A1 (da) |
IL (3) | IL144503A0 (da) |
MX (1) | MXPA01007451A (da) |
NZ (1) | NZ513164A (da) |
WO (1) | WO2000043395A1 (da) |
ZA (1) | ZA200106107B (da) |
Families Citing this family (54)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5747026A (en) * | 1993-10-15 | 1998-05-05 | University Of Alabama At Birmingham Research Foundation | Antioxidants |
US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
WO1999023097A1 (en) * | 1997-11-03 | 1999-05-14 | Duke University | Substituted porphyrins |
CA2329751C (en) | 1998-04-24 | 2010-10-12 | Duke University | Substituted porphyrins |
DK1155019T3 (da) | 1999-01-25 | 2006-04-18 | Nat Jewish Med & Res Center | Substituerede porphyriner og deres terapeutiske anvendelse |
FR2806911B1 (fr) * | 2000-03-28 | 2003-01-10 | Univ Rene Descartes | Utilisation de mimetiques de la sod dans le traitement d'insuffisances hepatocellulaires |
US20030069281A1 (en) * | 2000-06-14 | 2003-04-10 | Irwin Fridovich | Tetrapyrroles |
DE60233317D1 (de) * | 2001-01-19 | 2009-09-24 | Nat Jewish Med & Res Center | Medikament zum schutz in der radiotherapie |
CN1310907C (zh) * | 2001-04-27 | 2007-04-18 | 全药工业株式会社 | 杂环化合物和以其为有效成分的抗肿瘤药 |
EP1439842A4 (en) * | 2001-06-01 | 2009-09-02 | Nat Jewish Med & Res Center | OXIDANT CAPTAIN FOR THE TREATMENT OF DIABETES OR FOR THE USE IN THE TRANSPLANTATION OR INDUCTION OF IMMUNOTOLERANE |
US20030086916A1 (en) * | 2001-10-12 | 2003-05-08 | Goligorsky Michael S. | Use of peroxynitrite scavengers or peroxynitrite formation inhibitors that do not diminish nitric oxide synthesis or activity to reverse or prevent premature vascular senescence |
AU2003237500A1 (en) * | 2002-06-07 | 2003-12-22 | Duke University | Substituted porphyrins |
US20040127479A1 (en) * | 2002-08-27 | 2004-07-01 | Merck Patent Gmbh | Peroxynitrite rearrangement catalysts |
BR0317026A (pt) * | 2002-12-06 | 2005-10-25 | Alcon Inc | Mìmicos de superóxido dismutase para o tratamento de distúrbios e doenças oculares |
GB2397067B (en) * | 2002-12-23 | 2005-05-11 | Destiny Pharma Ltd | Porphin & azaporphin derivatives with at least one cationic-nitrogen-containing meso-substituent for use in photodynamic therapy & in vitro sterilisation |
EP1452175A1 (en) * | 2003-02-28 | 2004-09-01 | Medesis Pharma S.A. | Manganese based organometallic complexes, pharmaceutical compositions and dietetic products |
US20080161255A1 (en) * | 2003-05-29 | 2008-07-03 | Michael Brownlee | Use of Parp Inhibitors for Prevention and Treatment of Diabetic and Insulin Resistance Complications |
US7299082B2 (en) | 2003-10-31 | 2007-11-20 | Abbott Diabetes Care, Inc. | Method of calibrating an analyte-measurement device, and associated methods, devices and systems |
WO2005077269A1 (en) | 2004-02-09 | 2005-08-25 | Duke University | Substituted porphyrins |
US8165651B2 (en) * | 2004-02-09 | 2012-04-24 | Abbott Diabetes Care Inc. | Analyte sensor, and associated system and method employing a catalytic agent |
US7699964B2 (en) | 2004-02-09 | 2010-04-20 | Abbott Diabetes Care Inc. | Membrane suitable for use in an analyte sensor, analyte sensor, and associated method |
CA2561266A1 (en) | 2004-03-29 | 2005-10-20 | Inotek Pharmaceuticals Corporation | Pyridyl-substituted porphyrin compounds and methods of use thereof |
GB2415372A (en) | 2004-06-23 | 2005-12-28 | Destiny Pharma Ltd | Non photodynamical or sonodynamical antimicrobial use of porphyrins and azaporphyrins containing at least one cationic-nitrogen-containing substituent |
WO2006037050A2 (en) * | 2004-09-24 | 2006-04-06 | Metaphore Pharmaceuticals, Inc. | Methods for treating congestive heart failure |
GB0424294D0 (en) * | 2004-11-03 | 2004-12-01 | Elam T Ltd | Buffer layer |
US7501508B2 (en) * | 2005-07-29 | 2009-03-10 | North Caroline State University | Methods and intermediates for the synthesis of porphyrins |
US7582751B2 (en) * | 2005-07-29 | 2009-09-01 | North Carolina State University | Methods and intermediates for the synthesis of porphyrins |
US7885698B2 (en) | 2006-02-28 | 2011-02-08 | Abbott Diabetes Care Inc. | Method and system for providing continuous calibration of implantable analyte sensors |
EP2106445A2 (en) * | 2006-12-01 | 2009-10-07 | Loma Linda University Medical Center | Inhibition of brain enzymes involved in cerebral amyloid angiopathy and macular degeneration |
US20080289053A1 (en) * | 2007-05-15 | 2008-11-20 | The Regents Of The University Of California | Methods and systems for identifying modulators of longevity |
WO2009004339A2 (en) * | 2007-07-03 | 2009-01-08 | Imperial Innovations Limited | Compositions and methods relating to manipulation of the myeloid immune compartment during respiratory infection |
US8791099B2 (en) * | 2007-08-28 | 2014-07-29 | Technion Research And Development Foundation Ltd. | Transition metal complexes of corroles for preventing cardiovascular diseases or disorders |
US8598150B1 (en) | 2008-04-02 | 2013-12-03 | Jonathan R. Brestoff | Composition and method for affecting obesity and related conditions |
US8987245B2 (en) | 2008-04-02 | 2015-03-24 | Jonathan R. Brestoff Parker | Composition and method for affecting obesity and related conditions |
ES2600469T3 (es) | 2008-05-23 | 2017-02-09 | National Jewish Health | Un compuesto para su uso en el tratamiento de lesiones asociadas con la exposición al gas fosgeno o al gas de cloro |
EP2435387A4 (en) * | 2009-05-26 | 2013-03-20 | Univ Duke | PROCESS FOR PROVIDING NERVE PROTECTION THROUGH THE USE OF PORPHYRINES |
EP2473171A2 (en) * | 2009-09-02 | 2012-07-11 | The Regents of the University of Colorado, a body corporate | Methods of treating mitochondrial disorders using metalloporhyrins |
ES2574789T3 (es) * | 2010-10-06 | 2016-06-22 | Aeolus Sciences, Inc. | Tratamiento de porfirina de enfermedades neurodegenerativas |
WO2012105483A1 (ja) * | 2011-01-31 | 2012-08-09 | 国立大学法人宇都宮大学 | ポルフィリン型骨格を有する化合物の金属錯体の製造方法 |
JP2015500244A (ja) | 2011-12-02 | 2015-01-05 | ザ・リージエンツ・オブ・ザ・ユニバーシテイ・オブ・コロラド、ア・ボデイー・コーポレイト | メタロポルフィリン神経学処置 |
CN102775415B (zh) * | 2012-07-10 | 2014-10-22 | 西北大学 | 一种卟啉的合成方法 |
US20140085895A1 (en) * | 2012-08-16 | 2014-03-27 | Thomas Frawley | LED Bracket Apparatus for High-Output LED Lighting Systems |
US20160113940A1 (en) | 2013-09-03 | 2016-04-28 | Biomimetix J.V., Llc | Methods of treating biofilms |
BR112016011632A2 (pt) * | 2013-11-22 | 2017-08-08 | Aeolus Sciences Inc | Método para sintetizar um derivado de porfirina, método para sintetizar um composto, método para sintetizar um composto hidrato, método de síntese, recipiente compreendendo uma pluralidade de compostos, formulação farmacêutica, método para purificar um composto, cristal, e, forma cristalina de complexo [5,10,15,20-tetrakis(1,3-dietilimidazólio-2-il)porfirinato]manganês(iii) cloreto hidrato |
CN105899132B (zh) | 2013-12-31 | 2020-02-18 | 雅培糖尿病护理公司 | 自供电分析物传感器以及使用其的装置 |
US10064871B2 (en) | 2014-01-22 | 2018-09-04 | Biomimetix Jv, Llc | Methods of treating skin disorders |
WO2015112586A1 (en) | 2014-01-22 | 2015-07-30 | Duke University | Methods of treating pruritus |
AT516549B1 (de) * | 2014-11-20 | 2017-05-15 | Wenatex Forschung - Entw - Produktion Gmbh | Antimikrobielles Mittel zum biociden Ausrüsten von Polymeren |
WO2017031173A1 (en) | 2015-08-18 | 2017-02-23 | University Of Pittsburgh - Of The Commonwealth System Of Higher Education | Viologen-functionalized porphyrins for reducing biofouling on surfaces |
CN110291060A (zh) * | 2016-12-20 | 2019-09-27 | 杜克大学 | 制备取代卟啉药物化合物和组合物的方法 |
CN115505280A (zh) * | 2016-12-21 | 2022-12-23 | 普罗菲尤萨股份有限公司 | 可聚合的近红外染料 |
CN110028514B (zh) * | 2019-05-30 | 2021-07-02 | 湖南科技大学 | 5,10,15,20-四芳基-2,3-咪唑稠合-21-碳叶绿素化合物及制备方法 |
CA3143430A1 (en) * | 2019-06-14 | 2020-12-17 | Universidade De Coimbra | Small cationic ortho-5,15-di-heteroaryl-porphyrins derivatives and their applications in photoinactivation of microorganisms |
CN116284017B (zh) * | 2023-03-27 | 2024-03-22 | 中国科学院青岛生物能源与过程研究所 | 一种利用仿酶高效催化氧化制备酰胺化合物的方法 |
Family Cites Families (123)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US437221A (en) * | 1890-09-30 | Circular-saw-smithing machine | ||
US2951799A (en) | 1957-11-13 | 1960-09-06 | Monsanto Chemicals | Photoxidation processes using heterocyclic photosensitizers |
JPS5641611B2 (da) * | 1973-04-19 | 1981-09-29 | ||
EP0127797B1 (de) | 1983-06-03 | 1987-06-16 | F. HOFFMANN-LA ROCHE & CO. Aktiengesellschaft | Markermoleküle für Fluoreszenz-Immuno-Assays sowie Verfahren und Zwischenprodukte zu deren Herstellung |
US4829984A (en) | 1983-12-15 | 1989-05-16 | Gordon Robert T | Method for the improvement of transplantation techniques and for the preservation of tissue |
US4963367A (en) | 1984-04-27 | 1990-10-16 | Medaphore, Inc. | Drug delivery compositions and methods |
US5087438A (en) | 1984-07-03 | 1992-02-11 | Gordon Robert T | Method for affecting intracellular and extracellular electric and magnetic dipoles |
US4911920A (en) | 1986-07-30 | 1990-03-27 | Alcon Laboratories, Inc. | Sustained release, comfort formulation for glaucoma therapy |
GB8429845D0 (en) | 1984-11-26 | 1985-01-03 | Efamol Ltd | Porphyrins & cancer treatment |
US4758422A (en) | 1985-01-04 | 1988-07-19 | Salutar Inc. | Ferrioxamine paramagnetic contrast agents for MR imaging |
US4657902A (en) | 1985-03-25 | 1987-04-14 | The Rockefeller University | Therapeutic use of tin mesoporphyrin |
EP0223831B1 (en) | 1985-05-22 | 1992-07-15 | Liposome Technology, Inc. | Liposome inhalation method and system |
US5248603A (en) | 1985-09-03 | 1993-09-28 | Symbicom Aktiebolag | Superoxide dismutase |
DK402785D0 (da) | 1985-09-03 | 1985-09-03 | Syn Tek Ab | Fremgangsmaade til fremstilling af et enzym |
FR2588189B1 (fr) | 1985-10-03 | 1988-12-02 | Merck Sharp & Dohme | Composition pharmaceutique de type a transition de phase liquide-gel |
US4866054A (en) | 1986-05-13 | 1989-09-12 | Chai-Tech Corporation | Antioxidant metallo-organic treatment of inflammation |
US4746735A (en) | 1986-11-21 | 1988-05-24 | The Dow Chemical Company | Regiospecific aryl nitration of meso-substituted tetraarylporphyrins |
US5162231A (en) | 1989-10-25 | 1992-11-10 | Cole Dean A | Method of using 5,10,15,20-tetrakis(carboxyphenyl)porphine for detecting cancers of the lung |
ATE132902T1 (de) | 1987-03-14 | 1996-01-15 | Boehringer Ingelheim Int | Humane mangan-superoxiddismutase (hmn-sod) |
DE3800973C2 (de) * | 1987-03-25 | 1992-03-19 | Degussa Ag, 6000 Frankfurt, De | Oxowolfram(v)-porphyrin-komplexe wo(p)x |
US5227405A (en) | 1987-03-31 | 1993-07-13 | Duke University | Superoxide dismutase mimic |
US5223538A (en) | 1987-03-31 | 1993-06-29 | Duke University | Superoxide dismutase mimic |
US4892941A (en) | 1987-04-17 | 1990-01-09 | Dolphin David H | Porphyrins |
US4851403A (en) | 1987-04-21 | 1989-07-25 | Johnson Matthey, Inc. | Radiation sensitizers |
US4885114A (en) | 1987-04-22 | 1989-12-05 | Barnes Engineering Co. | Metallized tetra((meso)-5-methyl-2-thiophene)porphines, platinum (5-bromo octaethylporphine) and optical filters containing same |
US5051337A (en) | 1987-06-10 | 1991-09-24 | Director-General Of Agency Of Industrial Science And Technology | Optical recording material |
DE3805697A1 (de) * | 1988-02-24 | 1989-09-07 | Bayer Ag | Verfahren zur herstellung von p-hydroxy-benzaldehyden |
US5162519A (en) | 1988-03-11 | 1992-11-10 | Efamol Holdings Plc | Porphyrins and cancer treatment |
GB8805849D0 (en) | 1988-03-11 | 1988-04-13 | Efamol Holdings | Porphyrins & cancer treatment |
US5284647A (en) | 1988-03-18 | 1994-02-08 | Schering Aktiengesellschaft | Mesotetraphenylporphyrin complex compounds, process for their production and pharmaceutical agents containing them |
DE3809671A1 (de) | 1988-03-18 | 1989-09-28 | Schering Ag | Porphyrin-komplexverbindungen, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische mittel |
US5109016A (en) | 1988-05-23 | 1992-04-28 | Georgia State University Foundation, Inc. | Method for inhibiting infection or replication of human immunodeficiency virus with porphyrin and phthalocyanine antiviral compositions |
US5192788A (en) | 1988-05-23 | 1993-03-09 | Georgia State University Foundation, Inc. | Porphyrin antiviral compositions |
FR2632187B1 (fr) | 1988-06-02 | 1990-09-14 | Centre Nat Rech Scient | Derives de metalloporphyrines, leur preparation, leur application en therapeutique et leur utilisation pour la preparation de molecules hybrides |
US5171680A (en) | 1988-06-14 | 1992-12-15 | Chiron Corporation | Superoxide dismutase analogs having novel binding properties |
JPH0746212B2 (ja) | 1988-12-03 | 1995-05-17 | 工業技術院長 | 異方性lb膜の製造法 |
JPH02213088A (ja) * | 1989-02-13 | 1990-08-24 | Nec Corp | 有機薄膜el素子及びその製造方法 |
EP0414915B1 (en) | 1989-03-06 | 1996-06-12 | Suntory Limited | New superoxide dismutase |
DK455789D0 (da) | 1989-09-15 | 1989-09-15 | Symbicom Ab | Polypeptid |
US5010073A (en) | 1989-10-05 | 1991-04-23 | The Rockefeller University | Use of liposomes as carriers for metalloporphyrins |
EP0424033A3 (en) | 1989-10-19 | 1991-07-31 | Pola Chemical Industries Inc | External skin preparation |
US5236915A (en) | 1990-05-31 | 1993-08-17 | Health Research, Inc. | Meso poly(4-sulfonatophenyl) porphines as MRI image enhancing agents |
EP0462836A3 (en) | 1990-06-20 | 1992-08-26 | Mitsui Toatsu Chemicals, Inc. | Recombinant vector plasmid capable of expressing human manganese superoxide dismutase, and process of producing this enzyme |
US5417111A (en) * | 1990-08-17 | 1995-05-23 | Analog Devices, Inc. | Monolithic chip containing integrated circuitry and suspended microstructure |
US5217966A (en) | 1990-09-13 | 1993-06-08 | The Regents Of The University Of California | Synthetic drug molecules that mimic metalloenzymes |
US5202317A (en) | 1990-09-13 | 1993-04-13 | The Regents Of The University Of California | Synthetic drug molecules that mimic metalloenzymes |
AU8947791A (en) | 1990-11-01 | 1992-05-26 | Scripps Research Institute, The | Glycosaminoglycan-targeted fusion proteins, their design, construction and compositions |
JPH06504041A (ja) | 1990-11-14 | 1994-05-12 | ユー・エー・ビー・リサーチ ファウンデーション | 虚血性傷害を減少させる方法と組成 |
US5192757A (en) | 1990-12-20 | 1993-03-09 | Glaxo Inc. | Cobalt porphyrins |
ATE141502T1 (de) | 1991-01-15 | 1996-09-15 | Alcon Lab Inc | Verwendung von karrageenan in topischen ophthalmologischen zusammensetzungen |
GB9103991D0 (en) | 1991-02-26 | 1991-04-10 | Nat Res Dev | Molecular electronic devices |
US5212162A (en) | 1991-03-27 | 1993-05-18 | Alcon Laboratories, Inc. | Use of combinations gelling polysaccharides and finely divided drug carrier substrates in topical ophthalmic compositions |
FR2676738B1 (fr) | 1991-05-22 | 1995-05-05 | Ir2M | Nouveau derive organique de metal de transition a structure porphyrinique, composition therapeutique le contenant, en particulier a activite hypoglycemiante. |
DE69224839T2 (de) | 1991-07-19 | 1998-10-08 | Monsanto Co | Mangan-Komplexe mit Stickstoff enthaltenden makrozyklischen Liganden, wirksam als Superoxiddismutasekatalysatoren. |
CA2072934C (en) | 1991-07-19 | 2007-08-28 | Karl William Aston | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
US5262532A (en) | 1991-07-22 | 1993-11-16 | E.R. Squibb & Sons, Inc. | Paramagnetic metalloporphyrins as contrast agents for magnetic resonance imaging |
US5212300A (en) | 1991-09-12 | 1993-05-18 | Sun Company, Inc. (R&M) | Cyano- and polycyanometallo-porphyrins as catalysts for alkane oxidation |
US6011146A (en) | 1991-11-15 | 2000-01-04 | Institut Pasteur | Altered major histocompatibility complex (MHC) determinant and methods of using the determinant |
US5493017A (en) | 1992-08-14 | 1996-02-20 | The Trustees Of The University Of Pennsylvania | Ring-metalated porphyrins |
US5599924A (en) | 1992-08-14 | 1997-02-04 | Trustees Of The University Of Pennsylvania | Electron-deficient porphyrins and processes and intermediates for preparing same |
US5371199B1 (en) | 1992-08-14 | 1995-12-26 | Univ Pennsylvania | Substituted porphyrins porphyrin-containing polymers and synthetic methods therefor |
ATE201595T1 (de) | 1992-09-03 | 2001-06-15 | Univ California | Metallporphyrinzusammensetzungen |
US5403834A (en) | 1992-12-07 | 1995-04-04 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US5696109A (en) | 1992-12-07 | 1997-12-09 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US5834509A (en) | 1992-12-07 | 1998-11-10 | Eukarion, Inc. | Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease |
US6204259B1 (en) | 1993-01-14 | 2001-03-20 | Monsanto Company | Manganese complexes of nitrogen-containing macrocyclic ligands effective as catalysts for dismutating superoxide |
DE4305523A1 (de) | 1993-02-17 | 1994-08-18 | Diagnostikforschung Inst | Meso-Tetraphenylporphyrin-Komplexverbindungen, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Mittel |
US5428037A (en) | 1993-04-09 | 1995-06-27 | Syntex Pharmaceuticals, Ltd. | Heterocyclic derivatives in the treatment of Ischaemia and related diseases |
JP3273082B2 (ja) | 1993-06-18 | 2002-04-08 | 三和電気工業株式会社 | 光コネクタ用スリ−ブホルダ |
JPH0743337A (ja) * | 1993-07-30 | 1995-02-14 | Toppan Printing Co Ltd | マンガンポルフィリン錯体を感応物質とする陰イオン選択性電極 |
US6417182B1 (en) | 1993-08-25 | 2002-07-09 | Anormed Inc. | Pharmaceutical compositions comprising metal complexes |
US5747026A (en) | 1993-10-15 | 1998-05-05 | University Of Alabama At Birmingham Research Foundation | Antioxidants |
US6127356A (en) | 1993-10-15 | 2000-10-03 | Duke University | Oxidant scavengers |
US5994339A (en) | 1993-10-15 | 1999-11-30 | University Of Alabama At Birmingham Research Foundation | Oxidant scavengers |
US5488145A (en) | 1993-12-23 | 1996-01-30 | Oklahoma Medical Research Foundation | 2,4-disulfonyl phenyl butyl nitrone, its salts, and their use as pharmaceutical free radical traps |
US5608054A (en) | 1993-12-29 | 1997-03-04 | Sun Company, Inc. (R&M) | Porphyrins and metal complexes thereof having haloalkyl side chains |
US5405369A (en) | 1994-01-25 | 1995-04-11 | Medical College Of Ohio | Photochemical ablation of gastro-intestinal tissue for augmentation of an organ |
US5604199A (en) | 1994-03-29 | 1997-02-18 | The Nemours Foundation | Method of treating fibrosis in skeletal muscle tissue |
HUT76327A (en) * | 1994-05-13 | 1997-08-28 | Monsanto Co | Pharmaceutical compositions catalyzing decomposition of peroxy-nitrite |
US6245758B1 (en) | 1994-05-13 | 2001-06-12 | Michael K. Stern | Methods of use for peroxynitrite decomposition catalysts, pharmaceutical compositions therefor |
US5563132A (en) | 1994-06-21 | 1996-10-08 | Bodaness; Richard S. | Two-step cancer treatment method |
WO1996009053A1 (en) | 1994-09-20 | 1996-03-28 | Duke University | Oxidoreductase activity of manganic porphyrins |
CA2132690A1 (en) | 1994-09-22 | 1996-03-23 | Dean Willis | Control and modulation of inflammatory response in humans in need of such control and modulation |
US6013241A (en) | 1995-01-23 | 2000-01-11 | Schering Aktiengesellschaft | Use of porphyrin-complex or expanded porphyrin-complex compounds as an infarction localization diagnosticum |
CA2223407C (en) * | 1995-06-07 | 2011-02-08 | Duke University | Oxidant scavengers |
AU700958B2 (en) | 1995-08-17 | 1999-01-14 | Monsanto Company | Bioconjugates of manganese complexes and their application as catalysts |
WO1997006830A1 (en) | 1995-08-17 | 1997-02-27 | Monsanto Company | Methods of diagnostic image analysis using bioconjugates of metal complexes of nitrogen-containing macrocyclic ligands |
CA2229777A1 (en) | 1995-08-17 | 1997-02-27 | Monsanto Company | Methods of diagnostic image analysis using metal complexes of nitrogen-containing macrocyclic ligands |
US5648523A (en) | 1995-10-26 | 1997-07-15 | Chiang Long Y | Fullerene derivatives as free-radical scavengers |
US5948771A (en) | 1996-01-31 | 1999-09-07 | The Trustees Of Columbia University In The City Of New York | Method for treating heart failure using tetrapyrroles and metallotetrapyrroles |
AU2065697A (en) | 1996-03-13 | 1997-10-01 | Monsanto Company | Iron complexes of nitrogen-containing macrocyclic ligands effective as cataly sts for dismutating superoxide |
CN1225631A (zh) | 1996-03-13 | 1999-08-11 | 孟山都公司 | 有歧化过氧化物催化剂效果的含氮大环配位体锰或铁配合物的生物缀合物 |
JPH1062350A (ja) * | 1996-08-14 | 1998-03-06 | Ebara Corp | ガス反応性色素を用いたガス検知方法及びガス検知装置 |
US5756492A (en) | 1996-09-09 | 1998-05-26 | Sangstat Medical Corporation | Graft survival prolongation with porphyrins |
CA2283057A1 (en) | 1997-02-05 | 1998-08-06 | Board Of Regents, The University Of Texas System | Porphyrin compounds as telomerase inhibitors |
US6180620B1 (en) | 1997-06-20 | 2001-01-30 | G.D. Searle & Co. | Analgesic methods using synthetic catalysts for the dismutation of superoxide radicals |
US6214817B1 (en) | 1997-06-20 | 2001-04-10 | Monsanto Company | Substituted pyridino pentaazamacrocyle complexes having superoxide dismutase activity |
GB9716446D0 (en) | 1997-08-05 | 1997-10-08 | Agrevo Uk Ltd | Fungicides |
JP3564962B2 (ja) * | 1997-08-26 | 2004-09-15 | 松下電器産業株式会社 | 光記録媒体及びその光記録再生方法 |
AU8749598A (en) | 1997-08-26 | 1999-03-16 | Ihara Chemical Industry Co. Ltd. | Biarylalkylenecarbamic acid derivatives and bacteriocides for agricultural an d horticultural use |
WO1999023097A1 (en) | 1997-11-03 | 1999-05-14 | Duke University | Substituted porphyrins |
CA2329751C (en) * | 1998-04-24 | 2010-10-12 | Duke University | Substituted porphyrins |
CA2337756A1 (en) | 1998-07-23 | 2000-02-03 | Otto F. Schall | Libraries of polyhydroxamates and their analogs |
WO2000023568A2 (en) | 1998-10-06 | 2000-04-27 | Albert Einstein College Of Medicine Of Yeshiva University | Methods and compositions for decreasing mitochondrial overproduction of reactive oxygen species in cells |
DK1155019T3 (da) | 1999-01-25 | 2006-04-18 | Nat Jewish Med & Res Center | Substituerede porphyriner og deres terapeutiske anvendelse |
ATE291446T1 (de) | 1999-05-27 | 2005-04-15 | Monsanto Co | Biomaterialien, modifiziert mit superoxid- dismutase imitatoren |
US6448239B1 (en) | 1999-06-03 | 2002-09-10 | Trustees Of Princeton University | Peroxynitrite decomposition catalysts and methods of use thereof |
US6608050B2 (en) | 1999-07-20 | 2003-08-19 | Pharmacia & Upjohn Company | Lyophilizate of lipid complex of water insoluble porphyrins |
US6372727B1 (en) | 1999-10-13 | 2002-04-16 | Uab Research Foundation | Metalloporphyrin treatment of neurologic disease |
CA2360829A1 (en) | 1999-11-30 | 2001-06-07 | Isao Sakata | Nitroimidazole substituted porphyrin complex |
JP3383839B2 (ja) | 2000-03-13 | 2003-03-10 | 奈良先端科学技術大学院大学長 | 新規なメルカプト置換イミダゾリルポルフィリン金属錯体単量体及びこれを繰り返し単位として有する重合体並びにこれらの製造方法 |
US6624187B1 (en) | 2000-06-12 | 2003-09-23 | Health Research, Inc. | Long wave length absorbing bacteriochlorin alkyl ether analogs |
AU2001268366A1 (en) | 2000-06-14 | 2001-12-24 | Duke University | Tetrapyrroles |
US6403788B1 (en) | 2000-07-11 | 2002-06-11 | Eukarion, Inc. | Non-genotoxic metalloporphyrins as synthetic catalytic scavengers of reactive oxygen species |
US6573258B2 (en) | 2000-09-27 | 2003-06-03 | Frontier Scientific, Inc. | Photodynamic porphyrin antimicrobial agents |
DE60233317D1 (de) | 2001-01-19 | 2009-09-24 | Nat Jewish Med & Res Center | Medikament zum schutz in der radiotherapie |
EP1370240A4 (en) | 2001-03-02 | 2004-09-22 | Neuron Therapeutics Inc | NEUROPROTECTOR FORMULATIONS AND METHOD |
US6827926B2 (en) | 2001-05-31 | 2004-12-07 | Miravant Pharmaceuticals, Inc. | Metallotetrapyrrolic photosensitizing agents for use in photodynamic therapy |
US6566517B2 (en) | 2001-06-06 | 2003-05-20 | Brookhaven Science Associates, Llc | Metalloporphyrins and their uses as imageable tumor-targeting agents for radiation therapy |
DE10240343A1 (de) | 2002-08-27 | 2004-03-11 | Schering Ag | Peroxynitrit-Umlagerungskatalysatoren |
WO2005077269A1 (en) | 2004-02-09 | 2005-08-25 | Duke University | Substituted porphyrins |
US20090234011A1 (en) | 2005-04-21 | 2009-09-17 | Goldstein Glenn A | N-acetylcysteine amide (nac amide) for the treatment of diseases and conditions associated with oxidative stress |
EP2473171A2 (en) | 2009-09-02 | 2012-07-11 | The Regents of the University of Colorado, a body corporate | Methods of treating mitochondrial disorders using metalloporhyrins |
-
2000
- 2000-01-25 DK DK00905776T patent/DK1155019T3/da active
- 2000-01-25 WO PCT/US2000/002062 patent/WO2000043395A1/en active Application Filing
- 2000-01-25 CA CA002359116A patent/CA2359116C/en not_active Expired - Fee Related
- 2000-01-25 EP EP10011098A patent/EP2295435A1/en not_active Withdrawn
- 2000-01-25 IL IL14450300A patent/IL144503A0/xx active IP Right Grant
- 2000-01-25 AU AU27407/00A patent/AU779283B2/en not_active Ceased
- 2000-01-25 DK DK05014279.3T patent/DK1616869T3/da active
- 2000-01-25 KR KR1020017009367A patent/KR100753184B1/ko not_active IP Right Cessation
- 2000-01-25 CN CNB008054584A patent/CN1156478C/zh not_active Expired - Fee Related
- 2000-01-25 NZ NZ513164A patent/NZ513164A/xx not_active IP Right Cessation
- 2000-01-25 JP JP2000594811A patent/JP4501128B2/ja not_active Expired - Fee Related
- 2000-01-25 MX MXPA01007451A patent/MXPA01007451A/es active IP Right Grant
- 2000-01-25 EP EP05014279A patent/EP1616869B1/en not_active Expired - Lifetime
- 2000-01-25 AT AT00905776T patent/ATE312103T1/de not_active IP Right Cessation
- 2000-01-25 ES ES00905776T patent/ES2254142T3/es not_active Expired - Lifetime
- 2000-01-25 ES ES05014279T patent/ES2385486T3/es not_active Expired - Lifetime
- 2000-01-25 BR BRPI0007720-8B1A patent/BR0007720B1/pt not_active IP Right Cessation
- 2000-01-25 US US09/490,537 patent/US6544975B1/en not_active Expired - Lifetime
- 2000-01-25 EP EP00905776A patent/EP1155019B1/en not_active Expired - Lifetime
- 2000-01-25 DE DE60024588T patent/DE60024588T2/de not_active Expired - Lifetime
- 2000-01-25 AT AT05014279T patent/ATE552260T1/de active
-
2001
- 2001-07-23 IL IL144503A patent/IL144503A/en not_active IP Right Cessation
- 2001-07-25 ZA ZA200106107A patent/ZA200106107B/xx unknown
-
2002
- 2002-12-23 HK HK02109292A patent/HK1047744A1/xx not_active IP Right Cessation
-
2003
- 2003-01-23 US US10/349,171 patent/US7189707B2/en not_active Expired - Fee Related
-
2006
- 2006-05-08 HK HK06105351.6A patent/HK1083626A1/xx not_active IP Right Cessation
- 2006-06-16 US US11/424,662 patent/US7820644B2/en not_active Expired - Fee Related
-
2007
- 2007-06-14 IL IL183953A patent/IL183953A/en not_active IP Right Cessation
-
2010
- 2010-09-17 US US12/885,198 patent/US8217026B2/en not_active Expired - Lifetime
-
2012
- 2012-04-26 US US13/457,232 patent/US8546562B2/en not_active Expired - Fee Related
-
2013
- 2013-09-05 US US14/019,295 patent/US8946202B2/en not_active Expired - Fee Related
-
2014
- 2014-12-18 US US14/575,694 patent/US9289434B2/en not_active Expired - Fee Related
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK1155019T3 (da) | Substituerede porphyriner og deres terapeutiske anvendelse | |
ATE238307T1 (de) | Substituierte porphyrinen | |
DK1071474T3 (da) | Substituerede porphyriner | |
NO2022001I1 (no) | Pazopanib | |
NO20060971L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
EP1432714A4 (en) | CHEMICAL COMPOUNDS | |
NO20055130D0 (no) | Aminocykloheksyleter-forbindelser og deres anvendelse | |
HK1085461A1 (en) | Compounds, compositions and methods of treatment for heart failure | |
UA66865C2 (uk) | Інденопіролокарбазоли, фармацевтична композиція, спосіб інгібування кіназної активності та спосіб лікування (варіанти) | |
TR199902257T2 (xx) | Tetrahidropirido bile�ikleri | |
DE60325377D1 (de) | Motilidverbindungen | |
EP1436279A4 (en) | CHEMICAL COMPOUNDS |